Core Viewpoint - Meihua Medical reported a significant enhancement in profitability for the third quarter of 2025, with a year-on-year revenue increase and a proposed cash dividend distribution to shareholders [1] Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 1.194 billion yuan, representing a year-on-year growth of 3.28% [1] - The net profit for the same period was 208 million yuan [1] - In the third quarter alone, revenue reached 462 million yuan, marking a year-on-year increase of 2.56% [1] - The net profit for the third quarter was 93.9 million yuan, reflecting a year-on-year growth of 5.89% [1] Profit Distribution Plan - The company announced a profit distribution plan based on a total share capital of 569 million shares, proposing a cash dividend of 0.80 yuan for every 10 shares, totaling 45.42 million yuan (including tax) [1] - This distribution is aligned with the company's development stage and profitability, aiming to share operational results with shareholders [1] Business Strategy - Meihua Medical focuses on the design, manufacturing, and sales of precision components and products in the medical device sector, providing a comprehensive one-stop service [1] - The company aims to become a leading global medical technology service provider [1] - The growth in the medical device and CDMO industry is seen as a favorable external condition for business expansion [1] - A diversified business layout is identified as a long-term growth driver [1] - The company plans to expand its market focus on leading medical device enterprises in Europe and the United States, as well as localizing operations in China [1] - Collaborations with domestic and innovative high-tech medical enterprises are also highlighted as key future business priorities [1]